VistaGen Therapeutics (VTGN)
NASDAQ:VTGN
US Market

VistaGen Therapeutics (VTGN) Balance Sheet

755 Followers

VistaGen Therapeutics Balance Sheet

VistaGen Therapeutics's total assets for Q4 2024 were $123.69M, a decrease of -5.63% from the previous quarter. VTGN total liabilities were $9.37M for the fiscal quarter, a 20.35% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Assets
$ 123.69M$ 21.09M$ 74.64M$ 108.28M$ 5.77M
Total Liabilities
$ 9.37M$ 9.01M$ 9.93M$ 16.30M$ 11.50M
Total Equity Gross Minority
$ 114.30M$ 12.08M$ 64.72M$ 91.97M$ -5.73M
Total Capitalization
$ 115.87M$ 14.21M$ 64.72M$ 91.98M$ -5.73M
Preferred Stock Equity
----$ 4.00K
Capital Lease Obligations
----$ 4.04M
Currency in USD

VistaGen Therapeutics Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis